We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1B
AUM Growth
-$10.2M
Cap. Flow
-$19.8M
Cap. Flow %
-1.98%
Top 10 Hldgs %
3.73%
Holding
2,077
New
647
Increased
422
Reduced
386
Closed
620

Top Buys

Rank Stock Value
1
WEN icon
Wendy's
WEN
+$4.1M
2
DMC
Del Monte Corp
DMC
+$3.08M
3
SONO icon
Sonos
SONO
+$2.84M
4
IDXX icon
Idexx Laboratories
IDXX
+$2.8M
5
JBSS icon
John B. Sanfilippo & Son
JBSS
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 15.64%
2 Consumer Discretionary 14.23%
3 Healthcare 13.56%
4 Financials 11.82%
5 Industrials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLAC icon
701
KLA
KLAC
$259B
$534K 0.05%
+11,000
New +$460K
PDCO
702
DELISTED
Patterson Companies, Inc.
PDCO
$533K 0.05%
16,035
-3,410
-18% -$94K
RILY icon
703
BRC Group Holdings
RILY
$289M
$528K 0.05%
11,494
-8,897
-44% -$313K
LQDA icon
704
Liquidia Corp
LQDA
$8.02B
$527K 0.05%
67,140
+47,558
+243% +$370K
EDU icon
705
New Oriental
EDU
$8.98B
$526K 0.05%
13,321
-1,218
-8% -$48.7K
PLOW icon
706
Douglas Dynamics
PLOW
$1.02B
$524K 0.05%
+17,548
New +$515K
REE
707
DELISTED
REE Automotive
REE
$522K 0.05%
45,829
-11,095
-19% -$118K
CLDX icon
708
Celldex Therapeutics
CLDX
$3.28B
$520K 0.05%
15,312
-9,630
-39% -$325K
CHRS icon
709
Coherus Oncology
CHRS
$196M
$518K 0.05%
121,379
+55,702
+85% +$329K
TFC icon
710
Truist Financial
TFC
$64B
$518K 0.05%
+17,052
New +$530K
VRSN icon
711
VeriSign
VRSN
$26.6B
$518K 0.05%
2,294
-945
-29% -$208K
GEL icon
712
Genesis Energy
GEL
$1.84B
$516K 0.05%
53,988
-13,434
-20% -$139K
JBGS
713
JBG SMITH
JBGS
$708M
$516K 0.05%
+34,330
New +$500K
LKFN icon
714
Lakeland Financial Corp
LKFN
$1.53B
$516K 0.05%
+10,645
New +$557K
TRVG
715
trivago
TRVG
$397M
$516K 0.05%
78,239
+73,717
+1,630% +$472K
BRX icon
716
Brixmor Property Group
BRX
$9.32B
$515K 0.05%
23,407
-2,851
-11% -$59.5K
PCOR icon
717
Procore
PCOR
$8.67B
$514K 0.05%
7,894
-809
-9% -$47.6K
BKU icon
718
Bankunited
BKU
$3.36B
$513K 0.05%
+23,828
New +$490K
WAB icon
719
Wabtec
WAB
$49.3B
$512K 0.05%
4,667
+1,452
+45% +$144K
VLY icon
720
Valley National Bancorp
VLY
$8.04B
$510K 0.05%
+65,805
New +$523K
BG icon
721
Bunge Global
BG
$20.8B
$508K 0.05%
+5,384
New +$500K
NRP icon
722
Natural Resource Partners
NRP
$1.42B
$505K 0.05%
9,567
+2,825
+42% +$142K
BCRX icon
723
BioCryst Pharmaceuticals
BCRX
$2.4B
$504K 0.05%
71,532
-82,186
-53% -$660K
EWS icon
724
iShares MSCI Singapore ETF
EWS
$1.08B
$504K 0.05%
+27,219
New +$528K
FLIC
725
DELISTED
First of Long Island Corp
FLIC
$504K 0.05%
41,950
+1,853
+5% +$21.6K

Similar funds

GSA Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, GSA Capital Partners held 2,077 positions worth $1B, down 1% from $1.01B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners's Q2 2023 filing shows 647 new, 422 increased, 386 reduced and 620 closed positions. Its largest new stake was Sonos: 160,082 shares worth $2.61M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $7.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • GSA Capital Partners's largest Q2 2023 buy was Sonos: 160,082 shares worth $2.61M.
  • GSA Capital Partners added most to Wendy's in Q2 2023, an estimated $4.1M increase.
  • GSA Capital Partners's biggest Q2 2023 reduction was Arlo Technologies, cutting an estimated $3.67M.
  • GSA Capital Partners fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2023, selling an estimated $7.8M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $1B portfolio in Q2 2023.
  • GSA Capital Partners opened 647 new positions and closed 620 in Q2 2023.
  • GSA Capital Partners's portfolio value fell 1% quarter-over-quarter to $1B.

Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.